Dr. Marilyn Bui is a highly accomplished research-driven scientist whose scholarly work has made a substantial impact across pathology, oncology, digital pathology, and artificial intelligence–enabled diagnostics. Her research portfolio comprises 209 peer-reviewed publications, reflecting sustained productivity and leadership in translational and computational pathology. With 10,095 citations and an h-index of 51, her work demonstrates strong global influence and consistent citation performance across high-impact journals. Her research contributions span tumor biology, soft tissue and bone pathology, radiomics, digital and computational pathology, machine learning applications in diagnostics, and biomarker-driven precision medicine. She has played a pivotal role in advancing evidence-based pathology standards, multi-institutional consensus guidelines, and AI validation frameworks for clinical implementation. Through interdisciplinary collaborations, her research bridges molecular pathology, imaging analytics, and data science, supporting clinically actionable insights and innovation in cancer diagnostics. Her sustained citation impact and extensive publication record underscore her standing as a leading contributor to contemporary biomedical and translational pathology research.